IRIS
GARUTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.679
Totale 6.679
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.679
Totale 6.679
Salva come PNG Salva come JPEG
Città #
Genova 4.779
Rapallo 733
Genoa 669
Vado Ligure 486
Bordighera 12
Totale 6.679
Salva come PNG Salva come JPEG
Nome #
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 180
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 178
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 169
APO866 activity in hematologic malignancies: a preclinical in vitro study. 161
Ras-induced resistance to lapatinib is overcome by MEK inhibition 150
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 149
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 149
Uncovering the genomic heterogeneity of multifocal breast cancer 148
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 147
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 145
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 141
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 139
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 138
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 138
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 138
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 136
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 135
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 135
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 134
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 130
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 128
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 127
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 127
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 127
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 126
Germline mutations in the von Hippel-Lindau gene in Italian patients. 125
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 125
Mutant presenilin 1 increases the expression and activity of BACE1. 123
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 123
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 123
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 122
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 121
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 118
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 117
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 115
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 114
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 114
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 113
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 112
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 111
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 111
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 108
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 102
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 102
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 99
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 96
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 95
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 94
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 86
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 85
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 79
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 66
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 65
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 62
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 49
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 40
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 34
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 29
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 16
Totale 6.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.417
article - articoli 19.681
book - libri 0
conference - conferenze 492
curatela - curatele 0
other - altro 244
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.207 0 0 0 0 0 201 245 119 142 259 182 59
2020/2021523 30 81 30 42 32 30 28 54 45 60 55 36
2021/2022800 29 59 66 110 28 51 52 172 34 66 46 87
2022/2023900 94 98 10 100 147 121 10 65 134 1 113 7
2023/2024492 21 53 4 70 34 98 19 39 19 18 37 80
2024/2025518 47 86 43 90 153 99 0 0 0 0 0 0
Totale 6.769